BMHL vs SSBI

BMHL's deterministic health score is stable with a Piotroski F-Score of 6/9, indicating moderate financial health, but the absence of an Altman Z-Score limits bankruptcy risk assessment. Despite strong profitability metrics like a 30.26% ROE and low debt/equity of 0.09, the stock appears severely overvalued with a P/E of 73.90 versus a sector average of 20.86 and a Graham Number of just $0.48. Revenue growth is exceptional at 199.3% YoY, but earnings have declined by 43.4%, creating a fundamental disconnect. The technical trend is bearish, price performance over 1Y/3Y/5Y is negative, and insider sentiment is weak at 40/100, collectively signaling caution.

SSBI presents a contradictory profile characterized by a weak Piotroski F-Score of 3/9, indicating poor financial health, and a missing Altman Z-Score. While the stock trades below its Graham Number ($18.43) and Book Value (P/B 0.92), it is significantly overpriced relative to its growth-based Intrinsic Value of $7.07. Massive YoY revenue growth (327.5%) suggests a non-organic event or accounting shift, while a bearish technical trend (10/100) and low ROA (0.66%) signal underlying instability. The valuation is attractive from a defensive standpoint, but the fundamental health is concerning.